K
Power Law company profile
Krystal Biotech
Biotech & Life Sciences · Pittsburgh, United States · Founded 2016 · IPO 2017 Unicorn
Valuation
$6.83B
Market cap · Apr/2026
Revenue
$389M
Latest reported FY
Global footprint
Where Krystal Biotech has talent and traffic
Web traffic by country
16K
monthly visits
across markets
across markets
🇺🇸 United States48.8%
🇮🇳 India23.8%
🇬🇧 United Kingdom10.6%
🇨🇦 Canada8.8%
🇪🇸 Spain5%
Patent intelligence
$30M patent portfolio · 21 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$30M
0.44% of market cap · 2.8× smaller than top peer Twist Bioscience ($84M)
21 active patent families
Where Krystal Biotech innovates
PolynucleotideVirusNucleic acidDiseaseBioinformatics
Above peer median on Legal, Strategic, Market, Economic
Quality vs same-sector peers
Krystal Biotech on the five Patsnap quality dimensions
Krystal Biotech in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Krystal Biotech concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Krystal Biotech and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Krystal Biotech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.